Success Metrics

Clinical Success Rate
90.4%

Based on 47 completed trials

Completion Rate
90%(47/52)
Active Trials
3(5%)
Results Posted
74%(35 trials)
Terminated
5(8%)

Phase Distribution

Ph phase_3
25
42%
Ph phase_1
4
7%
Ph phase_4
3
5%
Ph early_phase_1
1
2%
Ph phase_2
26
43%
Ph not_applicable
1
2%

Phase Distribution

5

Early Stage

26

Mid Stage

28

Late Stage

Phase Distribution60 total trials
Early Phase 1First-in-human
1(1.7%)
Phase 1Safety & dosage
4(6.7%)
Phase 2Efficacy & side effects
26(43.3%)
Phase 3Large-scale testing
25(41.7%)
Phase 4Post-market surveillance
3(5.0%)
N/ANon-phased studies
1(1.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.5%

47 of 55 finished

Non-Completion Rate

14.5%

8 ended early

Currently Active

3

trials recruiting

Total Trials

60

all time

Status Distribution
Active(3)
Completed(47)
Terminated(8)
Other(2)

Detailed Status

Completed47
Terminated5
Withdrawn3
Recruiting2
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
60
Active
3
Success Rate
90.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (1.7%)
Phase 14 (6.7%)
Phase 226 (43.3%)
Phase 325 (41.7%)
Phase 43 (5.0%)
N/A1 (1.7%)

Trials by Status

unknown12%
recruiting23%
active_not_recruiting12%
suspended12%
completed4778%
terminated58%
withdrawn35%

Recent Activity

Clinical Trials (60)

Showing 20 of 60 trialsScroll for more
NCT06493578Phase 2

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo.

Terminated
NCT04886739Phase 2

CGB-400 Topical Gel for the Treatment of Inflammatory Lesions of Rosacea

Completed
NCT05005845Phase 2

NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

Completed
NCT07192588Phase 2

A Study of GR1014 Cutaneous Gel for the Prevention of Skin Reactions Caused by Radiation Therapy for Breast Cancer

Active Not Recruiting
NCT06154200Phase 2

Eyelid Androgen Treatment in Dry Eye

Completed
NCT02549352Phase 3

Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up

Completed
NCT03115476Phase 3

A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp

Terminated
NCT01600014Phase 3

Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp

Completed
NCT02547363Phase 3

Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up

Completed
NCT02547233Phase 3

Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up

Completed
NCT01461655Phase 2

Efficacy and the Tolerability of the Sequential Application of Two Marketed Products in Patients With Acne Vulgaris

Completed
NCT02549339Phase 3

Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-month Follow-up

Completed
NCT06444594Early Phase 1

Transient Receptor Potential Channels

Recruiting
NCT06108024Phase 2

A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis

Recruiting
NCT05511948Phase 2

Randomized and Open Label Study for Safety and Efficacy of DBI-102 vs. Vehicle vs. Hydroquinone on Skin Pigmentation and Lentigos

Completed
NCT03998436Phase 3

Phase 3 Study to Evaluate the Safety and Efficacy of Galnobax® in Treating Diabetic Foot Ulcers

Completed
NCT01796795Phase 2

Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients

Suspended
NCT02667444Phase 3

P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne

Completed
NCT02672332Phase 3

P3 Study in Acne Comparing Once Daily SB204 and Vehicle

Completed
NCT04684121Phase 2

Study of the Efficacy and Safety of Granexin® Gel to Improve Burn Wound Healing

Withdrawn

Drug Details

Intervention Type
DRUG
Total Trials
60